Brief: Moberg Pharma Q2 EBITDA Loss Narrows To SEK 8.5 Mln

Moberg Pharma AB (publ)

29/08/2019 07:24

Aug 29 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * Q2 EBITDA LOSS SEK 8.5 MILLION VERSUS LOSS SEK 11.1
MILLION YEAR
AGO
    * Q2 NET PROFIT AFTER TAX SEK -5.1 MILLION (4.7)
    * WITH SEK 919 MILLION IN CASH RESERVES AS AT JUNE 30, CO
HAS
SUFFICIENT FUNDS TO IMPLEMENT SHARE REDEMPTION AS PLANNED AND
FINALIZE CLINICAL PROGRAM FOR MOB-015

Source text for Eikon:  ID:nWkr2D6WnT 
Further company coverage:  MBPH.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))